Wedel, Germany (01/04/2024) medac GmbH proudly announces its participation as an official sponsor at the European Association of Urology (EAU) congress in Paris, France. The congress is scheduled to take place from April 5th to April 8th, 2024, at which medac GmbH will showcase its contributions to the field of urology.
With a commitment to improving human health, medac GmbH will be highlighting its expertise in instillation therapies for the treatment of non-muscle invasive bladder cancer (NMIBC). Representatives will be available at booth D42 throughout the congress to engage with attendees, share insights, and discuss the latest advancements in the field.
Moreover, medac GmbH proudly supports a hybrid symposium titled "Optimizing Outcomes for Patients With NMIBC - Challenges and Recent Developments in Clinical Practice" More information about this symposium can be found at this link: www.medscape.org/symposium/nmibc
The EAU congress serves as a premier platform for healthcare professionals, researchers, and industry leaders to exchange knowledge, collaborate on best practices, and explore emerging trends in urology. As an esteemed participant and official sponsor, medac GmbH reaffirms its dedication to supporting the global urology community in its mission to improve human health and drive scientific innovation.
